Resumo

APARICIO HERNANDEZ, R; GARCIA LUQUE, A; GRANDA LOBATO, P  e  CORREA PEREZ, A. Positive assessment of drugs: October, November and December 2019. Sanid. Mil. [online]. 2020, vol.76, n.1, pp.19-24.  Epub 05-Out-2020. ISSN 1887-8571.  https://dx.doi.org/10.4321/s1887-85712020000100004.

The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in October, November and December of 2019, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Brolucizumab (Beovu^®); Delafloxacino (Quofenix^®); Esketamina (Spravato^®); Fostamatinib (Tavlesse^®) Glucagón (Baqsini^®); Imipenem/Cilastatina/Rele­bactam (Recarbrio^®); Osilodrostat (Isturisa^®); Polatuzumab vedotin (Polivy^®); Romosozumab (Evenity^®); Siponimod (Mayzent^®); Solriamfetol (Sunosi^®);Upadacitinib (Rinvoq^®); Vacuna para ébola virus zaire (Ervebo^®).

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )